Atlas Global Announces Changes to Canadian Operations
CHATHAM, ONTARIO and TEL-AVIV, ISRAEL, June 02, 2023 (GLOBE NEWSWIRE) — Atlas Global Brands Inc….
News
loanDepot Makes Executive Changes and Streamlines Organization
Changes in line with Vision 2025 strategy David Hayes named Chief Financial Officer IRVINE, Calif.–(BUSINESS…
loanDepot Makes Executive Changes and Streamlines Organization
Changes in line with Vision 2025 strategy David Hayes named Chief Financial Officer IRVINE, Calif.–(BUSINESS…
Delaware Investments National Municipal Income Fund Announces Revised Fund Adoption Date
PHILADELPHIA–(BUSINESS WIRE)–Today, Delaware Investments National Municipal Income Fund (the “Fund”), a New York Stock Exchange…
Delaware Investments National Municipal Income Fund Announces Revised Fund Adoption Date
PHILADELPHIA–(BUSINESS WIRE)–Today, Delaware Investments National Municipal Income Fund (the “Fund”), a New York Stock Exchange…
Natuzzi S.p.A: First Quarter 2023 Financial Results and Shareholder Letter
First Quarter 2023 Highlights 1Q 2023 Invoiced Sales Amounted to €86.1 Million, a Decrease of…
Natuzzi S.p.A: First Quarter 2023 Financial Results and Shareholder Letter
First Quarter 2023 Highlights 1Q 2023 Invoiced Sales Amounted to €86.1 Million, a Decrease of…
FG Financial Group Announces Closing of Public Offering
ITASCA, Ill.–(BUSINESS WIRE)–FG Financial Group, Inc. (Nasdaq: FGF) (the “Company”), a reinsurance and asset management…
FG Financial Group Announces Closing of Public Offering
ITASCA, Ill.–(BUSINESS WIRE)–FG Financial Group, Inc. (Nasdaq: FGF) (the “Company”), a reinsurance and asset management…
Agra Ventures Announces Upcoming Annual General & Special Meeting
VANCOUVER, British Columbia, June 02, 2023 (GLOBE NEWSWIRE) — Agra Ventures Ltd. (“AGRA” or the…
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
– Additional data from Phase 1 combination with FOLFIRI continues to show encouraging activity in…
Elicio Therapeutics Reports Inducement Grant to New Chief Financial Officer
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Elicio Therapeutics (Nasdaq: ELTX), a clinical-stage biotechnology company…
Certara to Participate in the Jefferies Global Healthcare Conference
PRINCETON, N.J., June 02, 2023 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO and SAN DIEGO, June 02, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc….
Clarion Capital Partners Completes Investment in Ready Credit Corporation
NEW YORK–(BUSINESS WIRE)–On May 25, 2023, Clarion Capital Partners, LLC (“Clarion”) completed an investment in…
Clarion Capital Partners Completes Investment in Ready Credit Corporation
NEW YORK–(BUSINESS WIRE)–On May 25, 2023, Clarion Capital Partners, LLC (“Clarion”) completed an investment in…
Optinose to Present at the Jefferies Healthcare Conference
YARDLEY, Pa., June 02, 2023 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on…
Weights & Biases Unveils Lineup for Fully Connected Conference in San Francisco
Industry luminaries, including Wait But Why’s Tim Urban, to explore the best practices in generative…
LIXTE Biotechnology Holdings, Inc. Announces 1-for-10 Reverse Stock Split of its Common Stock Effective on Pre-Market Opening on June 5, 2023
PASADENA, CA, June 02, 2023 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the…
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
Phase 1 trial to resume with weekly dosing, a focus on patients with ovarian cancer…